Bellevue Group’s Nektar Therapeutics NKTR Stock Holding History

Bellevue Group’s Portfolio NKTR Stock Details NKTR Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,800	Closed	-$33.4K	–	169
2022 Q4	$33.4K	Hold	14,800	–	–	﹤0.01%	165
2022 Q3	$47K	Sell	14,800 -14,000	-49%	-$44.5K	﹤0.01%	168
2022 Q2	$109K	Sell	28,800 -4,779,601	-99%	-$18.1M	﹤0.01%	161
2022 Q1	$25.9M	Buy	4,808,401 +356,708	+8%	+$1.92M	0.3%	88
2021 Q4	$60.1M	Sell	4,451,693 -142,963	-3%	-$1.93M	0.62%	54
2021 Q3	$82.5M	Buy	4,594,656 +493,252	+12%	+$8.86M	0.84%	41
2021 Q2	$70.4M	Buy	4,101,404 +146,800	+4%	+$2.52M	0.69%	49
2021 Q1	$79.1M	Buy	3,954,604 +88,346	+2%	+$1.77M	0.84%	39
2020 Q4	$65.7M	Buy	3,866,258 +233,900	+6%	+$3.98M	0.75%	39
2020 Q3	$60.3M	Buy	3,632,358 +97,345	+3%	+$1.61M	0.83%	36
2020 Q2	$81.9M	Buy	3,535,013 +50,300	+1%	+$1.16M	1.16%	23
2020 Q1	$62.2M	Buy	3,484,713 +67,715	+2%	+$1.21M	1.21%	21
2019 Q4	$73.8M	Buy	3,416,998 +244,112	+8%	+$5.27M	1.17%	26
2019 Q3	$57.8M	Buy	3,172,886 +540,200	+21%	+$9.84M	1.07%	27
2019 Q2	$93.7M	Buy	2,632,686 +2,202,660	+512%	+$78.4M	1.6%	16
2019 Q1	$14.4M	Buy	430,026 +168,816	+65%	+$5.67M	0.8%	42
2018 Q4	$8.59M	Buy	261,210 +205,690	+370%	+$6.76M	0.56%	48
2018 Q3	$3.38M	Buy	55,520 +21,020	+61%	+$1.28M	0.21%	91
2018 Q2	$1.69M	Sell	34,500 -1,000	-3%	-$48.8K	0.14%	95
2018 Q1	$3.77M	Sell	35,500 -39,200	-52%	-$4.17M	0.37%	56
2017 Q4	$4.46M	Sell	74,700 -48,300	-39%	-$2.88M	0.47%	51
2017 Q3	$2.95M	Buy	123,000 +80,000	+186%	+$1.92M	0.31%	70
2017 Q2	$841K	Sell	43,000 -129,000	-75%	-$2.52M	0.1%	110
2017 Q1	$4.04M	Sell	172,000 -14,000	-8%	-$329K	0.54%	53
2016 Q4	$2.28M	Hold	186,000	–	–	0.47%	57
2016 Q3	$3.2M	Hold	186,000	–	–	0.58%	53
2016 Q2	$2.65M	Sell	186,000 -30,000	-14%	-$427K	0.5%	64
2016 Q1	$2.97M	Buy	+216,000	New	+$2.97M	0.54%	62